VITAMIN D DEFICIENCY AND FACTORS OF METABOLIC SYNDROME IN OVERWEIGHT AND OBESE ADOLESCENTS
Anna-Mariia Shulhai, О.М. Shulhai
openalex +1 more source
A contemporary simple risk score for prediction of severe AKI after HT. Abstract Background The aim of this study was to develop a simple risk score to estimate severe acute kidney injury (AKI) risk based on a large contemporary heart transplantation (HT) cohort.
Shuangshuang Zhu +10 more
wiley +1 more source
Intergenerational Transmission of Proactive Health Behaviors Among Adolescents with Overweight or Obesity: The Mediating Role of Self-Efficacy and Family Cohesion. [PDF]
Hu T +7 more
europepmc +1 more source
Socially Sustainable Interventions for Childhood Obesity Management: A Scoping Review of Randomized Controlled Trials. [PDF]
de Paula R +4 more
europepmc +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
The Association of Sugar-Sweetened Beverages Consumption Patterns and Overweight/Obesity: Evidence from a Large-Scale Survey of Chinese Children and Adolescents. [PDF]
Liu Y +6 more
europepmc +1 more source
Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen +7 more
wiley +1 more source
Evaluating algorithmic fairness of machine learning models in predicting underweight, overweight, and adiposity across socioeconomic and caste groups in India: evidence from the longitudinal ageing study in India. [PDF]
Lee JT +9 more
europepmc +1 more source
Use of glucagon‐like peptide‐1 receptor agonists in patients with left ventricular assist devices
Key question: does GLP1‐RA therapy improve heart transplantation rates and clinical outcomes in patients with LVADs? Key findings: in this propensity score‐matched cohort study of 1068 LVAD recipients, GLP1‐RA use was associated with higher heart transplantation rates (18.9% vs.
Ramzi Ibrahim +12 more
wiley +1 more source

